Login to Your Account



Amrad’s Stock Falls On Poor Phase II Results For Emfilermin

By Mark Lawson


Wednesday, March 27, 2002
No Abstract

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription